Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 6 PART I, 1998, Pages 1927-1934

  Lou, Ya Ping ^a   Takeyama, Kiyoshi ^a   Grattan, Kathleen M ^a   Lausier, James A ^a   Ueki, Iris F ^a   Agustí, Carlos ^a   Nadel, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CONTROLLED STUDY; GENE EXPRESSION; GOBLET CELL; GUINEA PIG; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA;

EID: 0031834909     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.6.9709113     Document Type: Article

References (24)

1. Venable, M. E., G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1993. Platelet-activating factor: a phospholipid autacoid with diverse actions. J. Lipid Res. 34:691-702.
2. Rieves, R. D., J. Goff, T. Wu, P. Larivee, C. Logun, and J. H. Shelhamer. 1992. Airway epithelial cell mucin release: immunologic quantitation and response to platelet-activating factor. Am. J. Respir. Cell Mol. Biol. 6:158-167.
3. Hotchkiss, J. A., M. A. Stam, and J. R. Harkema. 1993. Platelet-activating factor stimulates rapid mucin secretion in rat nasal airways in vivo. Exp. Lung Res. 19:545-557.
4. Hsieh, K. H., and C. K. Ng. 1993. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J. Allergy Clin. Immunol. 91:650-657.
5. Tsukioka, K., M. Matsuzaki, M. Nakamata, H. Kayahara, and T. Nakagawa. 1996. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Invest. Allergol. Clin. Immunol. 6:22-29.
6. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983-1991.
7. Triggiani, M., V. De Marino, M. Sofia, S. Faraone, G. Ambrosio, L. Carratu, and G. Marone. 1997. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 156:94-100.
8. Saetta, M., A. Di Stefano, C. Rosina, G. Thiene, and L. M. Fabbri. 1991. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am. Rev. Respir. Dis. 143:138-143.
9. Cardell, B. S., and R. S. B. Pearson. 1959. Death in asthmatics. Thorax 14:341-352.
10. Messer, J. W., G. A. Peters, and W. A. Bennett. 1960. Causes of death and pathological findings in 304 cases of bronchial asthma. Dis. Chest 38:616-624.
11. Dunhill, M. S. 1960. The pathology of asthma with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
12. Houston, J. C., S. De Navasquez, and J. R. Tounce. 1953. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 8:207-213.
13. Blyth, D. I., M. S. Pedrick, T. J. Savage, E. M. Hessel, and D. Fattah. 1996. Lung inflammation and epithelial change in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14:425-438.
14. Henderson, W. R., Jr., D. B. Lewis, R. K. Albert, Y. Zhang, W. J. Lamm, G. K. Chiang, F. Jones, P. Eriksen, Y. T. Tien, M. Jonas, and E. Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483-1494.
15. Broide, D. H., M. Lotz, J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
16. Narahara, H., and J. M. Johnston. 1993. Effects of endotoxins and cytokines on the secretion of platelet-activating factor-acetylhydrolase by human decidual macrophages. Am. J. Obstet. Gynecol. 169:531-537.
17. Guzman, K., T. Bader, and P. Nettesheim. 1996. Regulation of MUC5 and MUC1 gene expression: correlation with airway mucous differentiation. Am. J. Physiol. 270 (Lung Cell. Mol. Physiol. 14):L846-L853.
18. Harkema, J. R., and J. A. Hotchkiss. 1992. In vivo effects of endotoxin on intraepithelial mucosubstances in rat pulmonary airways. Am. J. Pathol. 141:307-317.
19. Noronha-Blob, L., V. C. Lowe, M. Weitzberg, and R. M. Burch. 1991. NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice. Ear. J. Pharmacol. 199:387-388.
20. Noronha-Blob, L., V. C. Lowe, R. O. Muhlhauser, and R. M. Burch. 1993. NPC 15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology 104:1021-1029.
21. Kaneko, T., P. G. Jorens, J. B. Y. Richman-Eisenstat, P. F. Dazin, and J. A. Nadel. 1994. Leumedin NPC 15669 inhibits antigen-induced recruitment of inflammatory cells into the canine airways. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11):L250-L255.
22. Temann, U.-A., B. Prasad, M. W. Gallup, C. Basbaum, S. B. Ho, R. A. Flavell, and J. Rankin. 1997. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16:471-478.
23. Thurlbeck, W. M., D. Malaka, and K. Murphy. 1975. Goblet cells in the peripheral airways in chronic bronchitis. Am. Rev. Respir. Dis. 112:65-69.
24. Boat, T. F., and R. C. Boucher. 1994. Cystic fibrosis. In J. F. Murray and J. A. Nadel, editors. Textbook of Respiratory Medicine. W. B. Saunders, Philadelphia. 1418-1450.